Skip to main content

Advertisement

SpringerLink
Log in

Impact of preoperative haemoglobin concentrations on the efficiency of KTP-laser vaporization of the prostate

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

The potassium-titanyl-phoshate laser (KTP laser) device produces light (wavelength of 532 nm) that is absorbed by haemoglobin, thus releasing thermal energy. This reaction causes vaporization of the tissue. We tested whether preoperative haemoglobin concentrations (Hb) affect the efficiency of the 80 W KTP laser, thus affecting the energy applied.

Methods

We assessed 164 patients undergoing KTP-laser vaporization for benign prostate hyperplasia from January 2005 to July 2006 at Heidelberg University Hospital. We prospectively collected data on patients’ demographics, urodynamics, Hb, prostate volume, and energy applied. We calculated the correlation between preoperative Hb and surgery energy applied and we adjusted it for prostate volume. We further compared the postoperative urinary flow and residual volume results in non-low-Hb and in low-Hb patients.

Results

The mean age was 68.8 (±8.8 years), the median prostate volume 50.0 mL (interquartile range 40–80), the median preoperative urinary flow 10.1 mL/s (interquartile range 7.1–14.0), the median surgery duration 70.0 min (interquartile range 50–92.75), the median preoperative Hb 144.5 g/L (interquartile range 132–151), and the median applied energy 209.5 kJ (interquartile range 156.5–272.75). The unadjusted correlation between preoperative Hb and applied energy was −0.089 (P < 0.05). After adjustment for prostate volume this correlation was not significant (Pearson r = −0.180, P > 0.05). Functional results did not differ between low-Hb and non-low-Hb patients (P > 0.05 for urinary flow and postvoid volume).

Conclusions

Haemoglobin concentrations, in the range of clinically encountered values, do not affect the efficiency of 80 W KTP-laser vaporization of the prostate. This laser technique is thus applicable in patients with low haemoglobin concentrations without concerns about efficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Madersbacher S, Alivizatos G, Nordling J et al (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554. doi:10.1016/j.eururo.2004.07.016

    Article  PubMed  Google Scholar 

  2. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ (2006) KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 20:580–585. doi:10.1089/end.2006.20.580

    Article  PubMed  Google Scholar 

  3. Heinrich E, Schiefelbein F, Schoen G (2007) Technique and short-term outcome of green light laser (KTP, 80 W) vaporisation of the prostate. Eur Urol 52:1632–1637. doi:10.1016/j.eururo.2007.07.033

    Article  PubMed  Google Scholar 

  4. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 100:593–598 (discussion 598). doi:10.1111/j.1464-410X.2007.06985.x

    Article  PubMed  Google Scholar 

  5. Reich O, Bachmann A, Siebels M et al (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173:158–160

    PubMed  Google Scholar 

  6. Tugcu V, Tasci AI, Sahin S et al (2007) Outcomes of 80 W KTP laser vaporization of the large prostate. Urol Int 79:316–320. doi:10.1159/000109716

    Article  PubMed  Google Scholar 

  7. Bachmann A, Ruszat R, Wyler S et al (2005) Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 47:798–804. doi:10.1016/j.eururo.2005.02.003

    Article  PubMed  Google Scholar 

  8. Te AE, Malloy TR, Stein BS et al (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233. doi:10.1111/j.1464-410X.2006.06197.x

    Article  PubMed  CAS  Google Scholar 

  9. Bloch W, Klotz T, Loch C et al (1997) Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate 33:1–8. doi:10.1002/(SICI)1097-0045(19970915)33:1<;1::AID-PROS1>;3.0.CO;2-P

    Article  PubMed  CAS  Google Scholar 

  10. Burnett AL, Maguire MP, Chamness SL et al (1995) Characterization and localization of nitric oxide synthase in the human prostate. Urology 45:435–439. doi:10.1016/S0090-4295(99)80012-0

    Article  PubMed  CAS  Google Scholar 

  11. Lange W, Unger J (1990) Peptidergic innervation within the prostate gland and seminal vesicle. Urol Res 18:337–340. doi:10.1007/BF00300783

    Article  PubMed  CAS  Google Scholar 

  12. Jungblut T, Aumuller G, Malek B, Melchior H (1989) Age-dependency and regional distribution of enkephalinergic nerves in human prostate. Urol Int 44:352–356

    Article  PubMed  CAS  Google Scholar 

  13. Zhu L, Pang L, Xu LX (2005) Simultaneous measurements of local tissue temperature and blood perfusion rate in the canine prostate during radio frequency thermal therapy. Biomech Model Mechanobiol 4:1–9. doi:10.1007/s10237-004-0061-8

    Article  PubMed  Google Scholar 

  14. Araki M, Lam PN, Culkin DJ, Wong C (2007) Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true? Urology 70:927–930. doi:10.1016/j.urology.2007.06.1152

    Article  PubMed  Google Scholar 

  15. Pinggera GM, Mitterberger M, Pallwein L et al (2008) Alpha-blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int 101:319–324. doi:10.1111/j.1464-410X.2007.07339.x

    Article  PubMed  CAS  Google Scholar 

  16. Berger AP, Bartsch G, Deibl M et al (2006) Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int 98:1038–1042. doi:10.1111/j.1464-410X.2006.06400.x

    Article  PubMed  Google Scholar 

  17. Berger AP, Horninger W, Bektic J et al (2006) Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU Int 98:587–590. doi:10.1111/j.1464-410X.2006.06306.x

    Article  PubMed  Google Scholar 

  18. Hamann MF, Wild C, Seif C et al (2007) Functional outcome after laser vaporisation of the prostate with the KTP laser. Urologe A 46(521–524):526–527

    Google Scholar 

  19. Park J, Song SH, Lee SB, Hong B, Ahu TY (2006) Photoselective vaporisation of the prostate for benign prostatic hyperplasia: comparison of short-term treatment outcomes with TURP. Eur Urol Suppl 5(2):235. doi:10.1016/S1569-9056(06)60856-7

    Article  Google Scholar 

  20. Ruszat R, Wyler S, Forster T et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51:1031–1038 (discussion 1038–1041). doi:10.1016/j.eururo.2006.08.006

    Article  PubMed  CAS  Google Scholar 

  21. Te AE, Malloy TR, Stein BS et al (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172:1404–1408. doi:10.1097/01.ju.0000139541.68542.f6

    Article  PubMed  Google Scholar 

  22. Volkan T, Ihsan TA, Yilmaz O et al (2005) Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 48:608–613. doi:10.1016/j.eururo.2005.07.013

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany

    Stephan Buse, Christian Gilfrich, Gencay Hatiboglu, Johannes Huber, Jens Bedke, Jesco Pfitzenmaier, Axel Haferkamp & Markus Hohenfellner

Authors
  1. Stephan Buse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Gilfrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gencay Hatiboglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johannes Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jens Bedke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jesco Pfitzenmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Axel Haferkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Markus Hohenfellner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephan Buse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buse, S., Gilfrich, C., Hatiboglu, G. et al. Impact of preoperative haemoglobin concentrations on the efficiency of KTP-laser vaporization of the prostate. World J Urol 27, 405–409 (2009). https://doi.org/10.1007/s00345-008-0363-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-008-0363-z

Keywords

Search

Navigation